| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |